TrumpRx, TrumpRx.gov, and prescription drug prices are all over the news and group chats right now and for good reason. In this episode, Robbie and Sam (both pharmacists) test the hype around TrumpRx.gov after its February 5, 2026 launch and explain what it actually is: a coupon style discount card, not a pharmacy, and not insurance.  

Robbie and Sam break down who benefits most from TrumpRx (uninsured patients, cash pay patients, and people whose insurance refuses to cover certain brand name meds like GLP 1 drugs) and who may not (insured patients whose copay beats the coupon, or anyone who needs the purchase to count toward a deductible or out of pocket maximum). They also call out the “discount math” that tricks people: a huge percent off a brand list price looks amazing on a headline, but if a generic already exists, the TrumpRx coupon price can be higher than what many people already pay. Protonix is a clean example. 👀

Bottom line: this isn’t a system overhaul. It’s a workaround. And whether it helps depends on where someone sits in the insurance maze. 

If this episode helps, hit like and subscribe. Comment with the most confusing part of prescription pricing, and share this with someone comparing TrumpRx to GoodRx or Cost Plus.

Rated Rx is a proud affiliate of the Pharmacy Podcast Network. 

This podcast is intended for entertainment and informational purposes only.